Daslemia 100mg Tablet is a prescription oral oncology medicine containing Dasatinib 100mg as its active ingredient. It belongs to the tyrosine kinase inhibitor class and is used under the supervision of a qualified oncologist for the treatment of specific types of blood cancers.
Daslemia 100 Tablet is commonly associated with the management of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and selected cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), depending on the patient’s diagnosis, disease phase, treatment history and medical response.
Marketed by Intas Pharmaceuticals Ltd, Daslemia 100mg is supplied in a pack of 30 tablets. Since this is a prescription oncology medicine, it should only be taken according to the exact instructions provided by the treating oncologist. Patients should not change the dose, skip regular monitoring or discontinue treatment independently.
Individuals searching for Daslemia 100mg Tablet, Daslemia 100 Tablet or Dasatinib 100mg tablets should review the medicine’s composition, therapeutic use, administration instructions, precautions and potential adverse effects before purchase or use.
What is Daslemia 100mg Tablet?
Daslemia 100mg Tablet is an oral medicine containing Dasatinib 100mg. Dasatinib is a targeted anticancer medicine that works by inhibiting specific abnormal tyrosine kinase proteins involved in the growth and survival of certain leukemia cells.
It is not a general-purpose medicine for all types of cancer. Its use depends on the presence of particular disease characteristics, including Philadelphia chromosome-positive disease in appropriate clinical situations.
Daslemia is prescribed by an oncologist after reviewing diagnostic reports, blood counts, disease status, previous treatment and the patient’s overall health condition.
Daslemia 100mg Composition
| Product Information | Details |
|---|---|
| Brand Name | Daslemia 100 |
| Active Ingredient | Dasatinib |
| Strength | 100mg |
| Dosage Form | Tablet |
| Pack Size | 30 Tablets |
| Manufacturer / Marketer | Intas Pharmaceuticals Ltd |
| Route | Oral |
The active pharmaceutical ingredient in Daslemia 100mg is Dasatinib. Always compare the strength and product name on the supplied pack with the oncologist’s prescription before taking the medicine.
Daslemia 100mg Tablet Uses
Daslemia 100mg Tablet is used for the treatment of specific blood cancers under specialist supervision. Dasatinib is indicated in selected patients with Philadelphia chromosome-positive leukemia, depending on the disease type and treatment setting.
- Specific forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
- Selected Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cases
- CML patients requiring dasatinib-based targeted treatment according to oncology guidance
- Patients who may have resistance or intolerance to certain previous leukemia treatments, depending on the clinical indication
The exact indication varies according to disease phase, age, prior treatment and the applicable prescribing information. Daslemia should never be used for an undiagnosed illness or for self-treatment of general weakness, anemia or unexplained blood abnormalities.
For general information about dasatinib and its medical use, refer to the
National Cancer Institute cancer information resources
and discuss the treatment plan with your oncology team.
How Does Daslemia Work?
Dasatinib is a tyrosine kinase inhibitor. Certain leukemia cells contain abnormal signaling proteins that continuously stimulate cell growth and survival. In Philadelphia chromosome-positive leukemia, the BCR-ABL signaling pathway plays an important role in abnormal cell proliferation.
Dasatinib inhibits BCR-ABL and other relevant kinase activity, thereby helping reduce abnormal signaling responsible for the growth of susceptible leukemia cells.
Because Dasatinib acts on specific molecular pathways, it is considered a targeted therapy rather than a conventional nonspecific medicine. The response to treatment is monitored through clinical assessment and laboratory investigations prescribed by the oncologist.
For detailed professional information, consult the
official Dasatinib prescribing information.
Daslemia 100mg Benefits
The potential benefits of Daslemia are related to its targeted anticancer action when used for an appropriate diagnosis and under specialist care.
- Targets abnormal kinase signaling involved in certain leukemia cells
- Helps inhibit the growth of susceptible Philadelphia chromosome-positive leukemia cells
- Provides an oral targeted-treatment option for selected blood cancer patients
- May be used in specific treatment settings involving CML or Ph+ ALL
- Can form part of a long-term oncology treatment plan when prescribed
- Allows treatment to be guided by disease monitoring and molecular response assessments
Clinical benefit varies from patient to patient. Daslemia is not expected to produce immediate symptom relief, and treatment response is evaluated using blood tests, molecular testing and other investigations as advised by the oncologist.
How to Take Daslemia 100mg Tablet
Take Daslemia exactly as prescribed by your oncologist. The medicine may be taken with or without food, but it is advisable to follow a consistent routine as instructed by the treating doctor.
- Take the tablet at the prescribed time each day.
- Swallow the tablet whole with water.
- Do not crush, chew, split or dissolve the tablet unless specifically instructed by your healthcare professional.
- Do not change the dose based on how you feel.
- Continue regular blood tests and oncology follow-up appointments.
- Keep the medicine away from children and other household members.
The product pack instructions specify that the tablet should be swallowed whole and not crushed or chewed. :contentReference[oaicite:3]{index=3}
Daslemia 100mg Dosage
The dosage of Daslemia is determined by the oncologist according to the type and phase of leukemia, age, previous treatment, blood counts, tolerability and treatment response.
For certain adult patients with chronic-phase CML, official dasatinib prescribing information lists 100mg once daily as a recommended starting dose. However, dosage differs for other disease phases and indications, and the patient must follow the individualized prescription rather than relying on a general dosage statement.
Do not increase or decrease the dose without medical approval. Dose interruptions or adjustments may be required if significant adverse effects, low blood cell counts, fluid retention or other treatment-related complications occur.
Official prescribing information describes different dosing recommendations according to disease phase and indication. :contentReference[oaicite:4]{index=4}
Missed Dose
If you miss a dose of Daslemia, follow the instructions provided by your oncologist or pharmacist. Do not take two doses together to compensate for a missed dose.
If you are unsure whether to take a missed dose, contact your oncology team for patient-specific advice, particularly if the next scheduled dose is approaching.
Daslemia 100mg Overdose
Taking more Daslemia than prescribed may increase the risk of serious adverse effects, including low blood cell counts, bleeding, fluid retention, gastrointestinal symptoms or heart-related complications.
If an overdose is suspected, seek urgent medical assistance or contact the treating oncology team immediately. Do not wait for symptoms to become severe.
Daslemia 100mg Side Effects
Dasatinib may cause side effects, although not every patient experiences them. Some effects may be manageable with supportive treatment or dose adjustment, while others require urgent medical attention.
Commonly Reported Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort or abdominal pain
- Headache
- Fatigue
- Skin rash
- Muscle or joint pain
- Fluid retention
- Reduced appetite
Important Serious Side Effects
- Low platelet count or thrombocytopenia
- Low white blood cell count or neutropenia
- Low hemoglobin or anemia
- Unusual bleeding or bruising
- Fluid accumulation around the lungs
- Shortness of breath
- Severe infection due to reduced blood cell counts
- Heart rhythm abnormalities
- Severe allergic reactions
Contact your oncologist promptly if you develop fever, unusual bleeding, black stools, severe breathlessness, chest discomfort, sudden swelling, persistent dizziness or significant changes in your health.
Daslemia Warnings and Precautions
Before starting Daslemia, inform your oncologist about your complete medical history and all medicines you are taking.
- Inform your doctor if you have a history of heart rhythm problems.
- Tell your doctor if you have liver disease or other significant medical conditions.
- Inform your healthcare team about previous bleeding episodes.
- Tell your doctor if you have low platelet, white blood cell or hemoglobin levels.
- Report breathlessness, chest pain or swelling immediately.
- Do not stop treatment without oncology guidance.
- Attend all scheduled blood tests and follow-up visits.
- Avoid self-medication with medicines that may interact with Dasatinib.
Dasatinib treatment may require regular monitoring of blood counts and other clinical parameters because it can affect blood cell production and may cause fluid retention or other significant complications.
Daslemia Drug Interactions
Dasatinib can interact with several medicines and substances. Provide your oncologist with a complete list of prescription medicines, over-the-counter products, supplements and herbal preparations.
Medicines Requiring Special Attention
- Strong CYP3A4 inhibitors
- Strong CYP3A4 inducers
- Medicines that affect heart rhythm
- Anticoagulants and antiplatelet medicines
- Other medicines that increase bleeding risk
- Acid-reducing medicines, including certain antacids and acid-suppressing drugs
- Other anticancer medicines
Some medicines can increase or decrease Dasatinib levels in the blood, potentially affecting effectiveness or toxicity. Do not start a new medicine without informing your oncology team.
Daslemia and Antacids
Antacids and acid-reducing medicines may affect the absorption of Dasatinib. The timing of antacids and other gastric acid-suppressing medicines should be discussed with your oncologist or pharmacist.
Do not take antacids or acid-reducing medicines at the same time as Daslemia unless your healthcare provider has given specific instructions.
Daslemia and Grapefruit
Grapefruit and grapefruit juice may affect the metabolism of Dasatinib and can increase medicine exposure. Patients taking Daslemia should discuss grapefruit consumption with their treating doctor and follow the prescribing information.
Pregnancy and Breastfeeding
Daslemia is a potent prescription oncology medicine and may cause harm to an unborn baby. Inform your oncologist if you are pregnant, planning pregnancy or could become pregnant.
Women and men receiving Dasatinib should discuss appropriate contraception and family-planning precautions with their oncology team.
Breastfeeding is generally not recommended during treatment with Dasatinib because of the potential for serious adverse effects in a breastfed infant. Follow your oncologist’s instructions regarding breastfeeding and treatment timing.
Daslemia Use in Children
Dasatinib may be used in selected pediatric leukemia treatment settings under specialist oncology supervision. Pediatric dosing is based on age, body weight or body surface area, diagnosis and treatment protocol.
Do not give Daslemia 100mg tablets to a child unless specifically prescribed by a pediatric oncologist.
Daslemia Use in Elderly Patients
Older adults may require closer monitoring during Dasatinib treatment because of age-related medical conditions, other medicines and increased susceptibility to certain adverse effects.
The oncologist may monitor blood counts, fluid retention, cardiovascular status and treatment tolerance more closely when clinically required.
Monitoring During Daslemia Treatment
Regular medical monitoring is an essential part of Daslemia treatment. Depending on the treatment plan, the oncologist may recommend:
- Complete blood count (CBC)
- Platelet and white blood cell monitoring
- Hemoglobin assessment
- Liver function tests when required
- Electrolyte monitoring
- Assessment for fluid retention
- Cardiac evaluation when clinically indicated
- Molecular response testing for CML
- Periodic oncology consultations
Do not skip scheduled investigations even if you feel well. Some treatment-related complications may develop before noticeable symptoms appear.
Storage Instructions
- Store Daslemia according to the instructions on the product packaging.
- Keep the tablets in the original packaging until use.
- Store at a temperature not exceeding the recommended limit.
- Keep away from excessive heat and moisture.
- Keep out of reach and sight of children.
- Do not use tablets after the expiry date.
- Do not use damaged or improperly stored tablets.
The available product information states storage below or not exceeding 30°C, depending on the pack information and product reference. Always follow the storage instructions printed on your actual medicine packaging. :contentReference[oaicite:5]{index=5}
Why Buy Daslemia 100mg Tablet from 24x7Pharma?
At 24x7Pharma, customers can explore prescription medicines and oncology products with clearly presented product information, composition details and pack-size information.
- Clear product information and medicine details
- Manufacturer and composition information
- Professional online pharmacy experience
- Access to prescription healthcare products
- Product information for informed medicine review
- Convenient online medicine browsing
Daslemia is a prescription oncology medicine. Customers should ensure that the product has been prescribed by a qualified oncologist and that the strength matches the prescription before placing an order.
Explore the
24x7Pharma prescription medicine collection
for additional healthcare products and oncology-related medicines.
Frequently Asked Questions
What is Daslemia 100mg Tablet?
Daslemia 100mg Tablet is a prescription oral medicine containing Dasatinib 100mg, a tyrosine kinase inhibitor used in selected blood cancer treatment settings.
What is Daslemia 100mg used for?
It is used under oncology supervision for specific types of Philadelphia chromosome-positive chronic myeloid leukemia and selected Philadelphia chromosome-positive acute lymphoblastic leukemia cases.
What is the composition of Daslemia 100 Tablet?
Daslemia 100 Tablet contains Dasatinib 100mg as its active ingredient.
Who manufactures Daslemia 100mg?
Daslemia 100mg is marketed by Intas Pharmaceuticals Ltd.
How many tablets are present in the pack?
The product pack shown is a 30-tablet pack.
Is Daslemia a chemotherapy medicine?
Daslemia contains Dasatinib, which is a targeted tyrosine kinase inhibitor. It is classified as an oral targeted anticancer medicine rather than conventional cytotoxic chemotherapy.
Can Daslemia be taken without a prescription?
No. Daslemia is a prescription oncology medicine and should only be used under the supervision of a qualified oncologist.
Can I stop Daslemia if I feel better?
No. Do not stop treatment without consulting your oncologist. Treatment duration depends on the disease and response to therapy.
Can Daslemia be taken with food?
Dasatinib may generally be taken with or without food, but patients should follow the specific instructions provided by their oncologist.
Should Daslemia tablets be crushed?
The tablet should be swallowed whole and should not be crushed or chewed unless specifically directed by a healthcare professional.
What should I do if I miss a dose?
Follow your oncologist’s missed-dose instructions. Do not take two doses together to compensate for a missed dose.
Does Daslemia require blood tests?
Yes. Regular blood tests are commonly required to monitor blood cell counts and assess treatment safety.
Can Daslemia cause low blood counts?
Dasatinib may reduce blood cell counts, including platelets, white blood cells and hemoglobin. Regular monitoring is important.
Can Daslemia cause fluid retention?
Fluid retention is a known potential adverse effect. Report swelling, unexplained weight gain or breathlessness to your healthcare provider.
Can I take antacids with Daslemia?
Antacids and acid-reducing medicines may affect Dasatinib absorption. Ask your oncologist or pharmacist about appropriate timing.
Can I drink grapefruit juice while taking Daslemia?
Grapefruit may interact with Dasatinib metabolism. Discuss grapefruit consumption with your oncology team.
Is Daslemia safe during pregnancy?
Daslemia may harm an unborn baby. Inform your oncologist immediately if you are pregnant or planning pregnancy.
What are common Daslemia side effects?
Possible side effects include nausea, diarrhea, vomiting, abdominal discomfort, rash, fatigue and fluid retention. Serious symptoms require prompt medical attention.
What should I do if I develop breathlessness?
Contact your oncologist promptly, especially if breathlessness is new, severe or associated with chest discomfort or swelling.
Medical Disclaimer
This product information is intended for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Daslemia 100mg Tablet is a prescription oncology medicine. It must be used only under the supervision of a qualified oncologist. Do not self-medicate, change the dose, stop treatment or combine it with other medicines without professional guidance.
Always read the product packaging and enclosed leaflet before use. Medicine availability, packaging, batch details and expiry may vary.
